Angiopoietin-1 promotes functional neovascularization that relieves ischemia by improving regional reperfusion in a swine chronic myocardial ischemia model.
暂无分享,去创建一个
Wei Li | Li Zhang | Ruowen Ge | Philip Wong | Li Zhang | W. Shim | P. Wong | E. Sim | R. Ge | Y. Lim | S. Chuah | Wei Li | Winston S N Shim | Shiqi Li | Hwee Choo Ong | In-Chin Song | Akanksha Bapna | Yean Teng Lim | Seng Chye Chuah | Eugene K W Sim | A. Bapna | H. Ong | I. Song | Shiqi Li | Akanksha Bapna
[1] W. Schaper,et al. Quantification of Collateral Resistance in Acute and Chronic Experimental Coronary Occlusion in the Dog , 1976, Circulation research.
[2] Brian H Annex,et al. Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis. , 2003, Journal of applied physiology.
[3] J. Isner,et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. , 1999, The Annals of thoracic surgery.
[4] J. Isner,et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. , 1999, Human gene therapy.
[5] B. Keyt,et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. , 1996, The Journal of surgical research.
[6] H. Blau,et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. , 2004, The Journal of clinical investigation.
[7] G. Koh,et al. Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. , 2001, Gastroenterology.
[8] S. Rafii,et al. Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells , 2001, The Journal of experimental medicine.
[9] L. Ye,et al. High efficiency transduction of human VEGF165 into human skeletal myoblasts: in vitro studies , 2003, Experimental & Molecular Medicine.
[10] J. Chae,et al. Coadministration of Angiopoietin-1 and Vascular Endothelial Growth Factor Enhances Collateral Vascularization , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[11] G. Koh,et al. Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. , 2000, Circulation research.
[12] L. Kedes,et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation. , 2000, Journal of the American College of Cardiology.
[13] L. Ye,et al. Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor , 2004, Journal of Molecular Medicine.
[14] D. Schiffer,et al. Expression of Angiopoietin-1 in Human Glioblastomas Regulates Tumor-Induced Angiogenesis: In Vivo and In Vitro Studies , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[15] M. Capogrossi,et al. Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs. , 2003, Human gene therapy.
[16] J. Longhurst,et al. Development of coronary collateral circulation in left circumflex Ameroid-occluded swine myocardium. , 1987, The American journal of physiology.
[17] W. Pearce,et al. Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. , 1999, The Annals of thoracic surgery.
[18] J. Lowe,et al. Intramyocardial and intracoronary basic fibroblast growth factor in porcine hibernating myocardium: a comparative study. , 2004, The Journal of thoracic and cardiovascular surgery.
[19] R. Coleman,et al. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF. , 2004, Annals of Thoracic Surgery.
[20] J. Isner,et al. Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia. , 2003, Life sciences.
[21] K. Sugimachi,et al. Angiogenic Gene Therapy for Experimental Critical Limb Ischemia: Acceleration of Limb Loss by Overexpression of Vascular Endothelial Growth Factor 165 but not of Fibroblast Growth Factor-2 , 2002, Circulation research.
[22] B. V. von Specht,et al. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. , 1998, Circulation.
[23] W. Schaper,et al. Time course of mitosis and collateral growth following coronary microembolization in the porcine heart , 1997, Cell and Tissue Research.
[24] W. Schaper,et al. Generation and localisation of monoclonal antibodies against fibroblast growth factors in ischaemic collateralised porcine myocardium. , 1993, Cardiovascular research.
[25] E. Unger,et al. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. , 1999, Cardiovascular research.
[26] T. Skalak,et al. Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. , 2004, American journal of physiology. Heart and circulatory physiology.
[27] S. Epstein,et al. Effects of gene delivery on collateral development in chronic hypoperfusion: diverse effects of angiopoietin-1 versus vascular endothelial growth factor. , 2004, Journal of the American College of Cardiology.
[28] C. Little,et al. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[29] L. Ye,et al. In vitro functional assessment of human skeletal myoblasts after transduction with adenoviral bicistronic vector carrying human VEGF165 and angiopoietin-1. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[30] M. Post,et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. , 1999, Circulation.
[31] L. Varticovski,et al. Opposing effect of angiopoietin‐1 on VEGF‐mediated disruption of endothelial cell–cell interactions requires activation of PKCβ , 2004, Journal of cellular physiology.
[32] M. Eskandarpour,et al. Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. , 2003, Biochemical and biophysical research communications.
[33] J. Kim,et al. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. , 2000, Circulation research.
[34] Armin Helisch,et al. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. , 2002, Journal of molecular and cellular cardiology.
[35] Pamela F. Jones,et al. Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.
[36] M. Teh,et al. Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice. , 2002, Experimental cell research.
[37] R. Crystal,et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. , 1998, The Journal of thoracic and cardiovascular surgery.
[38] J. Longhurst,et al. Effect of long-term exercise on regional myocardial function and coronary collateral development after gradual coronary artery occlusion in pigs. , 1990, Circulation.
[39] N. Copeland,et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] T. Takato,et al. Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor. , 2004, Cardiovascular research.
[41] Lei Xu,et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. , 2004, Cancer cell.
[42] D. Berman,et al. The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis , 2003, Circulation.
[43] R. Crystal,et al. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. , 1999, Human gene therapy.
[44] G. Lip,et al. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. , 2004, Journal of the American College of Cardiology.
[45] Pamela F. Jones,et al. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.
[46] M. Siemionow,et al. Enhancement of Muscle Flap Hemodynamics by Angiopoietin-1 , 2002, Annals of plastic surgery.
[47] H. Hamada,et al. Pre‐administration of angiopoietin‐1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model , 2003, The journal of gene medicine.
[48] J. Pearlman,et al. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. , 2000, Journal of the American College of Cardiology.
[49] J. Gamble,et al. Angiopoietin-1 Is an Antipermeability and Anti-Inflammatory Agent In Vitro and Targets Cell Junctions , 2000, Circulation research.
[50] T. Henry,et al. Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial , 2002, Circulation.
[51] Sachie Hirai,et al. Adenoviral-delivered angiopoietin-1 reduces the infarction and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[52] D. Warltier,et al. Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. , 2003, American journal of physiology. Heart and circulatory physiology.
[53] W. Sessa,et al. Antiangiogenic therapy: creating a unique "window" of opportunity. , 2004, Cancer cell.